HK1038009A1 - Tricyclic delta3-piperidines as pharmaceuticals. - Google Patents

Tricyclic delta3-piperidines as pharmaceuticals.

Info

Publication number
HK1038009A1
HK1038009A1 HK01108630A HK01108630A HK1038009A1 HK 1038009 A1 HK1038009 A1 HK 1038009A1 HK 01108630 A HK01108630 A HK 01108630A HK 01108630 A HK01108630 A HK 01108630A HK 1038009 A1 HK1038009 A1 HK 1038009A1
Authority
HK
Hong Kong
Prior art keywords
piperidines
pharmaceuticals
delta3
tricyclic
tricyclic delta3
Prior art date
Application number
HK01108630A
Other languages
English (en)
Inventor
Ludo Edmond Josephine Kennis
Josephus Carolus Mertens
Mirielle Braeken
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of HK1038009A1 publication Critical patent/HK1038009A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Psychology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HK01108630A 1998-10-06 2001-12-10 Tricyclic delta3-piperidines as pharmaceuticals. HK1038009A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98203371 1998-10-06
PCT/EP1999/007420 WO2000020423A1 (en) 1998-10-06 1999-10-01 Tricyclic δ3-piperidines as pharmaceuticals

Publications (1)

Publication Number Publication Date
HK1038009A1 true HK1038009A1 (en) 2002-03-01

Family

ID=8234192

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01108630A HK1038009A1 (en) 1998-10-06 2001-12-10 Tricyclic delta3-piperidines as pharmaceuticals.

Country Status (28)

Country Link
US (1) US6352999B1 (zh)
EP (1) EP1119570B1 (zh)
JP (1) JP4590102B2 (zh)
KR (1) KR20010071844A (zh)
CN (1) CN1131868C (zh)
AR (1) AR023679A1 (zh)
AT (1) ATE269337T1 (zh)
AU (1) AU759199B2 (zh)
BG (1) BG64871B1 (zh)
BR (1) BR9913108A (zh)
CA (1) CA2346082C (zh)
CZ (1) CZ20011105A3 (zh)
DE (1) DE69918148T2 (zh)
EE (1) EE04680B1 (zh)
ES (1) ES2222735T3 (zh)
HK (1) HK1038009A1 (zh)
HU (1) HUP0103749A3 (zh)
ID (1) ID28451A (zh)
IL (2) IL142444A0 (zh)
NO (1) NO20011402L (zh)
NZ (1) NZ510116A (zh)
PL (1) PL347179A1 (zh)
RU (1) RU2226194C2 (zh)
SK (1) SK285386B6 (zh)
TR (1) TR200100953T2 (zh)
TW (1) TWI244485B (zh)
UA (1) UA70961C2 (zh)
WO (1) WO2000020423A1 (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA69420C2 (uk) * 1998-10-06 2004-09-15 Янссен Фармацевтика Н.В. ТРИЦИКЛІЧНІ <font face="Symbol">D3</font>-ПІПЕРИДИНИ ЯК <font face="Symbol">a<sub></font>2</sub>-АНТАГОНІСТИ
WO2003004501A2 (en) * 2001-07-05 2003-01-16 Pharmacia & Upjohn Company (hetero) aryl substituted benzofurans as 5-ht ligands
EP1490338B1 (en) * 2002-04-03 2011-08-24 Orion Corporation Use of an alfa2-adrenoreceptor antagonist for cns-related diseases
BRPI0509893A (pt) 2004-04-12 2007-10-30 Taisho Pharmaceutical Co Ltd composto de amina cìclica
BRPI0608353A2 (pt) 2005-02-17 2009-12-01 Wyeth Corp derivados de indol, benzotiofeno, benzofurano e indeno cicloalquilfundidos
DE102005038947A1 (de) * 2005-05-18 2006-11-30 Grünenthal GmbH Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln
CN105636946B (zh) * 2013-07-25 2017-12-19 东亚St 株式会社 制备苯甲酰胺衍生物的方法、用于制备苯甲酰胺的新型中间体以及制备新型中间体的方法
CN103755715B (zh) * 2013-12-26 2015-12-09 武汉理工大学 苯并呋喃并[2,3-c]吡啶化合物及其合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3522959A1 (de) 1985-06-27 1987-01-08 Merck Patent Gmbh Indolderivate
US4673680A (en) * 1985-09-18 1987-06-16 Pendleton Robert G α2 -adrenergic receptor antagonists as modifiers of gastrointestinal motility
US4985422A (en) * 1988-04-27 1991-01-15 Glaxo Group Limited Lactam derivatives
US5100891A (en) * 1991-01-18 1992-03-31 Hoechst-Roussel Pharmaceuticals Inc. Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[B]indoles and related compounds
PT942911E (pt) * 1996-12-06 2002-04-29 Abbott Lab Compostos alfa 1 adrenergicos de benzopiranopirrolo e benzopiranopiridina
UA52681C2 (uk) * 1997-04-08 2003-01-15 Янссен Фармацевтика Н.В. Похідні 1,2,3,4-тетрагідро-бензофуро[3,2,-c]піридину, спосіб їх одержання та фармацевтична композиція на їх основі
UA69420C2 (uk) * 1998-10-06 2004-09-15 Янссен Фармацевтика Н.В. ТРИЦИКЛІЧНІ <font face="Symbol">D3</font>-ПІПЕРИДИНИ ЯК <font face="Symbol">a<sub></font>2</sub>-АНТАГОНІСТИ

Also Published As

Publication number Publication date
HUP0103749A3 (en) 2003-03-28
DE69918148T2 (de) 2005-07-28
EP1119570B1 (en) 2004-06-16
TWI244485B (en) 2005-12-01
BG64871B1 (bg) 2006-07-31
AU759199B2 (en) 2003-04-10
AU6334299A (en) 2000-04-26
BG105334A (en) 2001-11-30
UA70961C2 (uk) 2004-11-15
US6352999B1 (en) 2002-03-05
EE04680B1 (et) 2006-08-15
DE69918148D1 (de) 2004-07-22
JP4590102B2 (ja) 2010-12-01
ATE269337T1 (de) 2004-07-15
BR9913108A (pt) 2001-05-08
ES2222735T3 (es) 2005-02-01
SK4332001A3 (en) 2001-12-03
NO20011402D0 (no) 2001-03-20
NO20011402L (no) 2001-03-20
KR20010071844A (ko) 2001-07-31
WO2000020423A1 (en) 2000-04-13
EP1119570A1 (en) 2001-08-01
JP2002526547A (ja) 2002-08-20
ID28451A (id) 2001-05-24
SK285386B6 (sk) 2006-12-07
HUP0103749A2 (hu) 2002-02-28
IL142444A (en) 2008-03-20
CN1131868C (zh) 2003-12-24
IL142444A0 (en) 2002-03-10
CA2346082A1 (en) 2000-04-13
RU2226194C2 (ru) 2004-03-27
CA2346082C (en) 2010-02-16
CN1321158A (zh) 2001-11-07
NZ510116A (en) 2002-10-25
PL347179A1 (en) 2002-03-25
TR200100953T2 (tr) 2001-09-21
CZ20011105A3 (cs) 2001-12-12
AR023679A1 (es) 2002-09-04
EE200100210A (et) 2002-06-17

Similar Documents

Publication Publication Date Title
EG24814A (en) Novel compounds.
ZA996185B (en) Sulfanylsilanes.
ZA200005136B (en) Dihydropyrimides.
MXPA01013362A (es) Anticuerpos de humano, anti-alfavbeta3 recombinantes, °cidos nucleicos que codifican a los mismos y metodos de uso.
ZA99454B (en) Novel dosage form.
ZA200200477B (en) 2-pyrazolin-5-ones.
ZA99254B (en) Benzosulfone derivatives.
HK1054384A1 (en) 4-Pyrimidinyl-n-acyl-l-phenylalanines.
ZA200202537B (en) Pour-on-formulations.
ZA992772B (en) Substituted tricyclics.
ZA991272B (en) Novel thiobenzamides.
ZA200203762B (en) 4-pyridinyl-IN-acyl-L-phenylalanines.
ZA200005510B (en) Pharmaceutical composition.
ZA992072B (en) Substituted pyrroles.
ZA992443B (en) Hydroxy-methyl-hexanones.
ZA992773B (en) Substituted tricyclics.
ZA991550B (en) Cyclohexanediole derivatives.
ZA9811758B (en) Novel compounds.
HK1038009A1 (en) Tricyclic delta3-piperidines as pharmaceuticals.
ZA993123B (en) Trisresorcinyltriazines.
ZA995325B (en) Methylcyclotetradec-5-en-1-ones.
HK1036280A1 (en) Antivirals.
ZA9811503B (en) Novel compounds.
MXPA02000261A (es) Aminoindanos novedosos.
HK1044117A1 (en) Pharmaceutical composition.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20081001